COVID-19

Craig Burton from the AAM says patients must be able to access generics and biosimilars.

Find out about the five top trends that will shape biopharma manufacture in 2021.

How can the FDA tackle the inspection backlog?

We sit down with Jason Lacombe, CEO of Veratrak, to find out more about blockchain for pharma.

We catch up with Samsung Biologics about easing tech transfers and preparing plants for the future.

Sputnik V (finally and definitely) starts rolling review with the EMA.

How to add value and reduce risks with ethics.

We have vaccines. Now, pharma’s mission is to address novel variants. And vaccine hesitancy.

Pharma hasn’t always covered itself in glory – but as the world scrambles for viable COVID-19 interventions, it has a rare opportunity to rebrand.

The creators of the COVID-19 Curator give their perspectives on the pandemic and how it has changed their day-to-day lives.